Posted: Monday, January 1, 0001
Robert W. Carlson, MD, Chief Executive Officer of the National Comprehensive Cancer Network, describes JNCCN 360 Spotlight, original articles that dive deeply into the nuances of clinical medication use.
NEW Cemiplimab Combination Treatment for Solid Organ Transplant Recipients
UPDATE Cemiplimab in Cutaneous Squamous Cell Carcinoma
Cemiplimab-rwlc in Cutaneous Squamous Cell Carcinoma
ASCO: COVID-19 Medical Resources
Very Well Health - Skin Cancer
Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care Project
